Plasma thrombin-antithrombin complex as a candidate biomarker for coronary slow flow
BackgroundCoronary slow flow (CSF), characterized by delayed coronary perfusion without significant coronary artery stenosis, remains a diagnostic challenge due to its elusive pathophysiology. This retrospective study aimed to evaluate the association between the thrombin-antithrombin (TAT) complex...
Saved in:
| Main Authors: | Jian-hong Mo, Bo Liang, Jing-tao Cen, Wan-ying Li, Yong-an Mo, Ming-cheng Tang, Dong Ye, Qiu-xia Long, Xun Hu, Yuan-sheng Zhai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1621655/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Supplementation therapy with Antithrombin Drugs in the Combined Treatment of Sepsis
by: I. V. Redkin, et al.
Published: (2019-11-01) -
Identification of two point mutations associated with inherited antithrombin deficiency
by: Shiue-Wei Lai, et al.
Published: (2024-12-01) -
Comparative study of chromatographic properties of affinity resins in respect of protein of antithrombin III
by: М. А. Аzhigirova, et al.
Published: (2010-04-01) -
Protein C and antithrombin III deficiency in an elderly patient presenting with pulmonary embolism
by: R. Khan, et al.
Published: (2025-08-01) -
The impact of antithrombin III supplementation on prognosis during extracorporeal membrane oxygenation: a systematic review and meta-analysis
by: Ya-Ting Zeng, et al.
Published: (2025-12-01)